Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2019

01-08-2019 | Artificial Intelligence | Editorial

Improving Acute GI Bleeding Management Through Artificial Intelligence: Unnatural Selection?

Authors: Neil Sengupta, David A. Leiman

Published in: Digestive Diseases and Sciences | Issue 8/2019

Login to get access

Excerpt

Gastrointestinal bleeding (GIB) is the leading digestive disorder responsible for hospitalizations in the USA [1], a statistic not expected to change in the near future given the current shift of care toward more medically complex and anticoagulated patients, who are at increased risk for GIB. Accurate risk stratification of patients with GIB at initial presentation can facilitate improved triage efficiency and superior allocation of hospital-based resources. The ideal risk stratification tool should have both high positive and negative predictive values, which would result in low-risk patients’ discharge for outpatient follow-up and early endoscopy in those with high-risk predictors. A health system embracing this model would likely reduce costs while potentially improving meaningful clinical outcomes such as overall mortality and hospital length of stay. …
Literature
1.
go back to reference Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states: update 2018. Gastroenterology. 2019;156:254–272 e11.CrossRefPubMed Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states: update 2018. Gastroenterology. 2019;156:254–272 e11.CrossRefPubMed
2.
go back to reference Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356:1318–1321.CrossRefPubMed Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356:1318–1321.CrossRefPubMed
3.
go back to reference Leiman DA, Mills AM, Shofer FS, et al. Glasgow blatchford score of limited benefit for low-risk urban patients: a mixed methods study. Endosc Int Open. 2017;5:E950–E958.CrossRefPubMedPubMedCentral Leiman DA, Mills AM, Shofer FS, et al. Glasgow blatchford score of limited benefit for low-risk urban patients: a mixed methods study. Endosc Int Open. 2017;5:E950–E958.CrossRefPubMedPubMedCentral
4.
6.
go back to reference Henry KE, Hager DN, Pronovost PJ, et al. A targeted real-time early warning score (TREWScore) for septic shock. Sci Transl Med. 2015;7:299ra122.CrossRefPubMed Henry KE, Hager DN, Pronovost PJ, et al. A targeted real-time early warning score (TREWScore) for septic shock. Sci Transl Med. 2015;7:299ra122.CrossRefPubMed
7.
go back to reference Shameer K, Johnson KW, Yahi A, et al. Predictive modeling of hospital readmission rates using electronic medical record-wide machine learning: a case-study using mount sinai heart failure cohort. Pac Symp Biocomput. 2017;22:276–287.PubMed Shameer K, Johnson KW, Yahi A, et al. Predictive modeling of hospital readmission rates using electronic medical record-wide machine learning: a case-study using mount sinai heart failure cohort. Pac Symp Biocomput. 2017;22:276–287.PubMed
8.
go back to reference Oh J, Makar M, Fusco C, et al. A generalizable, data-driven approach to predict daily risk of clostridium difficile infection at two large academic health centers. Infect Control Hosp Epidemiol. 2018;39:425–433.CrossRefPubMedPubMedCentral Oh J, Makar M, Fusco C, et al. A generalizable, data-driven approach to predict daily risk of clostridium difficile infection at two large academic health centers. Infect Control Hosp Epidemiol. 2018;39:425–433.CrossRefPubMedPubMedCentral
9.
go back to reference Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44–56.CrossRefPubMed Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44–56.CrossRefPubMed
Metadata
Title
Improving Acute GI Bleeding Management Through Artificial Intelligence: Unnatural Selection?
Authors
Neil Sengupta
David A. Leiman
Publication date
01-08-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05698-0

Other articles of this Issue 8/2019

Digestive Diseases and Sciences 8/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.